Information received by previous manufacturer (apollo endosurgery) in a uk manufacturer incident report (uk reference number: (b)(4)) in which patient states: "i have been suffering from abdominal pain dysmotility of the oesophagus bowel blockage chestpain breathing difficulties gerd" patient also states in 3.2f (remedial actions taken by healthcare facility, patient, or user subsequent to the incident: "recalled by fda for safety issues tissue damage rupture and leak mri dangers wording changed i am concerned with links to breast implants re silicone toxicity and lymphoma cancers due to overgrowth of scar tissue" no other relevant information was provided.
|
Further information is expected from patient and associated healthcare providers.Codes specified in h6 health effect clinical code, health impact and h6: device problem codes are as reported from mhra mir report mir # ((b)(4)) and are being investigated pending further information.No new risks identified; the current risk is identified with a low rate of occurrence for the reported complaint categories.No correction or corrective action required.The lot history record for the complaint was not available to be reviewed.Unable to determine root cause.The investigation findings do not lead to a clear conclusion about the cause of the reported adverse event.If additional information becomes available for investigation in the future, a supplemental report would be made.At this time, the reported issue will be tracked and trended.
|